Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3233/JPD-202497 http://scihub22266oqcxt.onion/10.3233/JPD-202497 33935103!8355058!33935103     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Parkinsons+Dis 2021 ; 11 (3): 1057-1065 Nephropedia Template TP {{tp|p=33935103|t=2021. Barriers to Vaccination Among People with Parkinson s Disease and Implications for COVID-19 |pdf=|usr=}}{{33935103}} gab.com Text Barriers to Vaccination Among People with Parkinson s Disease and Implications for COVID-19 JO: J Parkinsons Dis http://www.kidney.de/pget.php?&tw=1&pmid=33935103 #FOAvip BACKGROUND: Patients with Parkinson's disease (PD) are at higher risk of vaccine-preventable respiratory infections. However, advanced, homebound individuals may have less access to vaccinations. In light of COVID-19, understanding barriers to vaccination in PD may inform strategies to increase vaccine uptake. OBJECTIVE: To identify influenza and pneumococcal vaccination rates, including barriers and facilitators to vaccination, among homebound and ambulatory individuals with PD and related disorders. METHODS: Cross-sectional US-based study among individuals with PD, aged > 65 years, stratified as homebound or ambulatory. Participants completed semi-structured interviews on vaccination rates and barriers, and healthcare utilization. RESULTS: Among 143 participants, 9.8% had missed all influenza vaccinations in the past 5 years, and 32.2% lacked any pneumococcal vaccination, with no between-group differences. Homebound participants (n = 41) reported difficulty traveling to clinic (p < 0.01) as a vaccination barrier, and despite similar outpatient visit frequencies, had more frequent emergency department visits (31.7% vs. 9.8%, p < 0.01) and hospitalizations (14.6% vs. 2.9%, p = 0.03). Vaccine hesitancy was reported in 35% of participants, vaccine refusal in 19%, and 13.3% reported unvaccinated household members, with no between-group differences. Nearly 13% thought providers recommended against vaccines for PD patients, and 31.5% were unsure of vaccine recommendations in PD. CONCLUSION: Among a sample of homebound and ambulatory people with PD, many lack age-appropriate immunizations despite ample healthcare utilization. Many participants were unsure whether healthcare providers recommend vaccinations for people with PD. In light of COVID-19, neurologist reinforcement that vaccinations are indicated, safe, and recommended may be beneficial. Twit Text FOAVip Barriers to Vaccination Among People with Parkinson s Disease and Implications for COVID-19 ????J Parkinsons Dis http://www.kidney.de/pget.php?&tw=1&pmid=33935103 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33935103 #FOAvip English Wikipedia <ref>{{Cite pmid|33935103}}</ref> Barriers to Vaccination Among People with Parkinson s Disease and Implications for COVID-19 #MMPMID33935103 Phanhdone T; Drummond P; Meisel T; Friede N; Di Rocco A; Chodosh J; Fleisher J J Parkinsons Dis 2021[]; 11 (3): 1057-1065 PMID33935103show ga BACKGROUND: Patients with Parkinson's disease (PD) are at higher risk of vaccine-preventable respiratory infections. However, advanced, homebound individuals may have less access to vaccinations. In light of COVID-19, understanding barriers to vaccination in PD may inform strategies to increase vaccine uptake. OBJECTIVE: To identify influenza and pneumococcal vaccination rates, including barriers and facilitators to vaccination, among homebound and ambulatory individuals with PD and related disorders. METHODS: Cross-sectional US-based study among individuals with PD, aged > 65 years, stratified as homebound or ambulatory. Participants completed semi-structured interviews on vaccination rates and barriers, and healthcare utilization. RESULTS: Among 143 participants, 9.8% had missed all influenza vaccinations in the past 5 years, and 32.2% lacked any pneumococcal vaccination, with no between-group differences. Homebound participants (n = 41) reported difficulty traveling to clinic (p < 0.01) as a vaccination barrier, and despite similar outpatient visit frequencies, had more frequent emergency department visits (31.7% vs. 9.8%, p < 0.01) and hospitalizations (14.6% vs. 2.9%, p = 0.03). Vaccine hesitancy was reported in 35% of participants, vaccine refusal in 19%, and 13.3% reported unvaccinated household members, with no between-group differences. Nearly 13% thought providers recommended against vaccines for PD patients, and 31.5% were unsure of vaccine recommendations in PD. CONCLUSION: Among a sample of homebound and ambulatory people with PD, many lack age-appropriate immunizations despite ample healthcare utilization. Many participants were unsure whether healthcare providers recommend vaccinations for people with PD. In light of COVID-19, neurologist reinforcement that vaccinations are indicated, safe, and recommended may be beneficial. |*Health Knowledge, Attitudes, Practice[MESH] |*Parkinson Disease[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/prevention & control[MESH] |Cross-Sectional Studies[MESH] |Facilities and Services Utilization/*statistics & numerical data[MESH] |Female[MESH] |Health Services Accessibility/*statistics & numerical data[MESH] |Humans[MESH] |Influenza Vaccines[MESH] |Male[MESH] |Mobility Limitation[MESH] |Patient Acceptance of Health Care/*statistics & numerical data[MESH] |Pneumococcal Vaccines[MESH] |United States[MESH]Barriers to Vaccination Among People with Parkinson s Disease and Impl(epmc).pdf DeepDyve Pubget Overpricing